KLK3 and prostate carcinoma: These immunomagnetic nanoparticle-based microfluidic sensors with screen-printed carbon electrodes (INμ-SPCEs) showed limits of detection of 0.23 pg·mL−1 for PSA and 0.30 pg·mL−1 for IL-6, measured in the serum of prostate cancer patients [26].